유병철

교수, 센터장
    

  #간암#간경변증#간염#헬스조선명의

학력

1986 | 서울대학교 의과대학원 졸업 (의학박사)
1980 | 서울대학교 의과대학원 졸업 (의학석사)
1977 | 서울대학교 의과대학 졸업 (의학사)

경력

2019-현재 | 건국대학교병원 임상의학연구소 건강고령사회연구원장
2015-현재 | 건국대학교병원 소화기센터 센터장
2015-2016 | 건국대학교 의학전문대학원장
2007-2012 | 삼성서울병원 소화기센터장
2004-2007 | 삼성서울병원 암센터장
2003-2004 | 삼성서울병원 건강의학센터장
1997-2002 | 중앙대학교 의대부속병원 내과 과장
1989-2002 | Fox Chase Cancer Center, Philadelphia. Post-doctoral Research Fellow

논문

Kwon BS, Choi WH, Kwon SY, Yoo BC, Park SJ, Kim JH. Comparison of the efficacy and safety of direct-acting antiviral therapy with or without hepatitis C-related hepatocellular carcinoma. Korean Journal of Internal Medicine. 2021 Mar;36(2):292-304.

Suh JW, Kwon BS, Lee TS, Kwon SY, Choi WH, Yoo BC, Shim CS, Yoon JM, Lee JH, Cheon YK. Prognostic impact of hepatitis B or C on intrahepatic cholangiocarcinoma. Korean Journal of Internal Medicine. 2020 May;35(3):566-73.

Lim YS, Gwak GY, Choi J, Lee YS, Byun KS, Kim YJ, Yoo BC, Kwon SY, Lee HC. Monotherapy with Tenofovir Disoproxil Fumarate for Adefovir-Resistant vs. Entecavir-Resistant Chronic Hepatitis B: a 5-Year clinical trial. Journal of Hepatology. 2019 Jul;71(1):35-44.

Kim AR, Park E, Kwon SY, Park SJ, Kim YJ, Yoo BC, Choe WH, Kim JH, Hwang JH, Park SW, Kim YJ, Park HS, Yu MH, Jeon HJ. Efficacy and Safety of Combined Radiofrequency Ablation with Transarterial Chemoembolization in Patients with Barcelona Clinic Liver Cancer Stage A Hepatocellular Carcinoma Ineligible for Curative Treatment. Korean Journal of Gastroenterology. 2019 Mar;73(3):167-176.

A comparison of clevudine and entecavir for treatment-naive patients with chronic hepatitis B: results after 2 years of treatment.. Gut. 2016 Jun;65(6) :1042-51.

A randomized, open-label study comparing low-dose clevudine plus adefovir combination therapy with clevudine monotherapy in naive chronic hepatitis B patients. Hepatol Int. 2014 : 375-381.

A comparison of clevudine and entecavir for treatment-naive patients with chronic hepatitis B: results after 2 years of treatment. Hepatol Int. 2013 : 106-110.

A comparison of clevudine and entecavir for treatment-naive patients with chronic hepatitis B: results after 2 years of treatment.. Hepatogastroenterology. 2013 : 328-332.

Glycyrrhizin attenuates HMGB1-induced hepatocyte apoptosis by inhibiting the p38-dependent mitochondrial pathway. World J Gastroenterol. 2012 : 679-684 .

The correlation of hepatitis B virus pre-S mutation with mitochondrial D-loop mutations and common deletions in hepatocellular carcinoma. Hepatogastroenterology. 2011 : 522-528 .

Superior long-term outcomes after surgery in child-pugh class a patients with single small hepatocellular carcinoma compared to radiofrequency ablation. Hepatol Int. 2011 : 722-729.

Clevudine-induced viral response, associated with continued reduction of HBsAg titer, was durable after the withdrawal of therapy. J Gastroenterol. 2011 : 410-414 .

Clinical significance of core gene mutations during the course of genotype C chronic hepatitis B virus infection. Hepatogastroenterology. 2011 : 1643-1647 .

The correlation of hepatitis B virus pre-S mutation with mitochondrial D-loop mutations and common deletions in hepatocellular carcinoma. Hepatol Int. 2011 : 664-670.

저서

제4판 김정룡 소화기계 질환

제3판 김정룡 소화기계 질환

제2판 김정룡 소화기계 질환

제2판 김정룡 소화기계 질환

김정룡 소화기계 질환

간담췌 외과학

임상내과학 I

보도자료

만성B형 간염, 치료의 패러다임이 변하고 있다 "바라크루드·비리어드 처방해 처음부터 내성 극복해야"
http://www.doctorsnews.co.kr/news/articleView.html?idxno=87184

포스팅

포스팅 내용이 없습니다.

영상자료

[연합뉴스] A, B, C형 간염 어떻게 예방하나?
https://www.yna.co.kr/view/MYH20160728020700797?input=1197m

[KBS 생로병사의 비밀] 생로병사의 비밀 - Mysteries of the Human Body 20080608 #003
https://www.youtube.com/watch?v=Sxyry7FisT8

[EBS 명의] 한국인의 성인병 명의에게 묻다 - 제3부 만성간 유병철 교수
https://bestdoctors.ebs.co.kr/bestdoctors/vodReplayView?siteCd=ME&prodId=454&courseId=BP0PAPG0000000014&stepId=01BP0PAPG0000000014&lectId=1191505

발표자료

발표자료 내용이 없습니다.